Schinus terebinthifolius administration prevented behavioral and biochemical alterations in a rotenone model of Parkinson's disease

AUTOR(ES)

Sereniki, Adriana, Linard-Medeiros, Cybelle F.B., Silva, Shirliane N., Silva, Juciene B.R., Peixoto Sobrinho, Tadeu J.S., Silva, Juliano R. da, Alves, Lariza D.S., Smaili, Soraya S., Wanderley, Almir G., Lafayette, Simone S.L.

FONTE

Rev. bras. farmacogn.

DATA DE PUBLICAÇÃO

2016-04

RESUMO

ABSTRACT Parkinson's disease is a neurodegenerative disorder characterized by motor impairment, cognitive decline and psychiatric symptoms. Schinus terebinthifolius Raddi, Anacardiaceae, had been studied for its anti-inflammatory and antioxidant properties, and in this study, the stem bark was evaluated for the neuroprotective effects on behavioral and biochemical alterations induced by administrations of rotenone in rats. Behavioral evaluations were performed using open-field and rotarod. The in vitro and in vivo antioxidant activities were determined by the DPPH radical scavenging activity and lipid peroxidation method respectively. The administration of rotenone (3 mg/kg, s.c.) produced hypolocomotion, increase of immobility and muscle incoordination, while the treatment with S. terebinthifolius stem bark extract (150, 300 and 600 mg/kg p.o.) for seven days prevented rotenone-induced dysfunctional behavior. Biochemical analysis of the substantia nigra, striatum and cortex revealed that rotenone administration significantly increased lipid peroxidation, which was inhibited by treatment with all doses of S. terebinthifolius. The results suggested neuroprotective effect of S. terebinthifolius possibly mediated through its antioxidant activity, indicating a potential therapeutic benefit of this species in the treatment of Parkinson's disease.

Documentos Relacionados

• Can falls be prevented in Parkinson's disease?
• Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease
• A New Cell Model for Parkinson's Disease
• parkin counteracts symptoms in a Drosophila model of Parkinson's disease
• Parkinson's disease and essential tremor in families of patients with early-onset Parkinson's disease.